studi
perform
develop
realtim
sinc
influenza
virus
subtyp
well
influenza
b
virus
respons
human
influenza
diseas
northern
hemispher
nevertheless
infect
highli
pathogen
avian
influenza
viru
observ
human
popul
accord
data
provid
world
health
organ
august
total
human
infect
caus
laboratori
confirm
fatal
case
report
sinc
thu
despit
fact
end
pandem
caus
announc
august
still
potenti
threat
anoth
influenza
pandem
caus
hpai
viru
certainli
high
level
changeabl
influenza
virus
togeth
anim
reservoir
pathogen
make
possibl
complet
new
viru
variant
pandem
potenti
emerg
therefor
highqual
surveil
togeth
avail
rapid
accur
diagnost
method
big
challeng
case
influenza
viru
infect
subtyp
influenza
virus
necessari
surveil
usual
less
import
diagnosi
individu
patient
ill
sinc
clinic
diagnosi
influenza
suffici
commenc
appropri
treatment
nevertheless
new
influenza
viru
variant
suspect
caus
human
infect
case
swine
origin
viru
subtyp
seem
justifi
necessari
differenti
new
variant
older
one
may
requir
appropri
control
infect
case
manag
especi
begin
new
outbreak
differ
laboratori
techniqu
may
use
diagnost
influenza
infect
nucleic
acid
amplif
techniqu
becom
use
rapid
specif
sensit
compar
method
improv
influenza
diagnost
depend
technic
capabl
laboratori
equip
also
skill
user
appli
piec
equip
optim
way
accomplish
specif
goal
therefor
mani
effort
undertaken
develop
multiplex
pcr
realtim
pcr
qpcr
reaction
enabl
differ
virus
differ
typessubtyp
viru
detect
singl
reaction
develop
multiplex
qpcr
reaction
difficult
task
especi
three
target
gene
detect
one
reaction
difficulti
caus
overlap
fluoresc
fluorophor
use
probe
label
anoth
difficulti
emerg
changeabl
influenza
virus
mostli
appli
gene
encod
haemagglutinin
ha
neuraminidas
na
determin
subtyp
influenza
viru
thu
design
appropri
primer
probe
enabl
detect
differ
virus
given
subtyp
big
challeng
paper
report
develop
optimis
three
qualit
twostep
duplex
qpcr
assay
detect
human
season
avian
influenza
virus
b
demonstr
high
specif
sensit
use
assay
primer
fluoresc
probe
base
taqman
chemistri
design
correspond
specif
highli
conserv
region
influenza
viru
haemagglutinin
season
influenza
virus
gene
influenza
viru
neuraminidas
gene
influenza
b
viru
yamagata
victoria
lineag
nonstructur
protein
ns
gene
specif
conserv
target
region
identifi
follow
multipl
align
nucleotid
sequenc
respect
hanan
gene
differ
influenza
viru
strain
avail
influenza
sequenc
databas
isd
genbank
databas
nation
center
biotechnolog
inform
primer
probe
set
tabl
sequenc
primer
probe
design
select
use
qpcr
assay
primer
probe
sequenc
analys
g
c
content
format
dimer
hairpin
secondari
structur
use
oligoanalyz
integr
dna
technolog
inc
http
euidtdnacomanalyz
applicationsoligoanalyz
specif
primer
probe
set
measur
use
blast
entir
human
genom
influenza
virus
target
one
prevent
amplif
nonspecif
sequencerel
secondari
product
oligonucleotid
synthesis
genom
sa
warsaw
poland
sequenc
primer
probe
shown
tabl
qiaamp
viral
rna
mini
kit
qiagen
germani
use
purifi
total
rna
allanto
fluid
refer
strain
clinic
specimen
dna
isol
bacteri
sampl
use
high
pure
viral
nucleic
acid
kit
roch
diagnost
isol
perform
accord
manufactur
instruct
extract
nucleic
acid
elut
final
volum
elut
buffer
isol
nucleic
acid
store
viral
rna
reversetranscrib
cdna
use
transcriptor
first
strand
cdna
synthesi
kit
roch
diagnost
random
hexam
primer
rna
templat
accord
manufactur
instruct
neg
control
includ
run
cdna
sampl
obtain
store
analysi
reaction
mixtur
contain
hot
start
pcr
buffer
thermoscientif
fermenta
dntp
mix
mm
mm
mgcl
lm
primer
u
maxima
hot
start
taq
dna
polymeras
thermoscientif
fermenta
cdna
influenza
b
steril
dnasernasefre
water
final
volum
amplif
perform
veriti
tm
thermal
cycler
appli
biosystem
inc
usa
follow
singl
cycl
initi
denaturationenzym
activ
min
cycl
denatur
min
anneal
extens
last
cycl
reaction
complet
final
extens
min
pcr
product
total
volum
separ
agaros
gel
stain
gelr
tm
solut
tae
buffer
generul
bp
dna
ladder
use
estim
molecular
size
band
obtain
thermoscientif
fermenta
order
optimis
reaction
monoplex
duplex
reaction
carri
lm
primer
nm
probe
assay
perform
twostep
reaction
use
lightcycl
taqman
master
kit
roch
diagnost
cdna
assay
optimis
use
one
ident
set
thermocycl
condit
fluoresc
level
measur
wavelength
nm
nm
end
elong
step
cycl
qpcr
reaction
data
analysi
perform
use
lightcycl
instrument
roch
diagnost
colour
compens
softwar
use
analysi
accord
manual
provid
roch
diagnost
cross
point
cp
valu
calcul
determin
point
pcr
cycl
fluoresc
intens
rise
background
detect
limit
posit
neg
control
includ
run
purpos
present
studi
develop
qualit
realtim
pcr
assay
detect
differenti
season
avian
influenza
virus
realtim
pcr
assay
first
perform
monospecif
assay
cdna
target
virus
optimis
increas
sensit
effici
amplif
monospecif
assay
combin
three
duplex
reaction
optimis
concentr
primer
probe
gave
best
result
follow
lm
influenza
viru
primer
lm
influenza
viru
bspecif
primer
nm
probe
total
volum
reaction
mixtur
duplex
realtim
pcr
system
use
identifi
subtyp
ii
subtyp
iii
subtyp
b
type
assay
perform
twostep
reaction
optimis
use
thermocycl
condit
best
amplif
result
obtain
activ
termost
hotstart
dna
polymeras
min
follow
cycl
compris
denatur
anneal
strand
elong
end
strandelong
step
singl
measur
fluoresc
perform
select
primer
probe
show
nonspecif
homolog
nucleotid
blast
search
includ
human
genom
influenza
virus
target
one
confirm
specif
experiment
assay
perform
nucleic
acid
isol
refer
strain
differ
influenza
virus
panel
common
human
respiratori
pathogen
list
materi
method
primerprob
set
detect
rna
cdna
correspond
viru
convent
pcr
well
newli
develop
qpcr
assay
monoplex
duplex
format
nonspecif
signal
observ
crossreact
common
viral
bacteri
respiratori
pathogen
fig
b
c
duplex
qpcr
combin
templat
differ
influenza
virus
gave
specif
proper
result
without
crosstalk
fluoresc
nm
channel
colour
compens
softwar
appli
present
studi
sampl
control
panel
previous
diagnos
posit
influenza
influenza
b
neg
influenza
monoplex
onestep
qpcr
convent
rtpcr
data
shown
use
evalu
clinic
use
newli
develop
assay
none
test
sampl
show
falseposit
result
nonspecif
signal
fig
b
c
posit
specimen
found
posit
test
use
duplex
qpcr
assay
despit
high
degre
genet
variabl
cocircul
differ
clade
subtyp
assay
identifi
ha
gene
current
circul
clade
examin
eight
neg
specimen
influenza
viru
b
detect
moreov
amplifi
product
visibl
agaros
gel
electrophoresi
qpcr
neg
sampl
result
confirm
sampl
specif
clinic
use
assay
qpcr
assay
serial
dilut
templat
contain
plasmid
dna
copi
success
detect
result
lod
duplex
qpcr
assay
express
dna
copi
per
reaction
tube
shown
tabl
total
respiratori
specimen
test
use
newli
develop
assay
standard
rapid
laboratori
method
monoplex
qpcr
recommend
cdc
result
monoplex
qpcr
consist
obtain
duplex
qpcr
ie
sampl
identifi
influenza
sampl
influenza
sampl
influenza
b
sampl
neg
influenza
viru
neither
fals
posit
fals
neg
result
observ
result
ifa
consist
qpcr
assay
specimen
influenza
posit
influenza
b
posit
influenza
b
neg
eight
specimen
neg
influenza
b
viru
assay
subsequ
determin
posit
qpcr
assay
influenza
n
n
b
n
three
specimen
posit
influenza
viru
assay
neg
qpcr
assay
posit
result
amplif
bactin
gene
obtain
sampl
earli
detect
virolog
surveil
influenza
viru
strain
circul
region
global
key
element
updat
influenza
vaccin
composit
epidemicpandem
prevent
control
cocircul
multipl
type
subtyp
season
influenza
virus
increas
difficulti
viru
identif
diagnosi
molecular
method
base
pcr
allow
rapid
accur
sensit
direct
detect
influenza
virus
includ
subtyp
influenza
viru
becom
valuabl
tool
routin
diagnost
well
surveil
howev
high
level
genet
variabl
influenza
virus
especi
among
virus
type
make
develop
specif
molecular
assay
difficult
simultan
changeabl
requir
diagnost
method
constantli
monitor
updat
event
emerg
new
genet
distinct
strain
mani
multiplex
qpcr
assay
detect
influenza
virus
develop
nevertheless
knowledg
one
paper
describ
multiplex
assay
detect
follow
influenza
virus
type
b
subtyp
without
differenti
season
thu
three
duplex
qpcr
assay
design
studi
concurr
detect
influenza
b
virus
offer
valuabl
strateg
diagnost
approach
could
routin
adapt
identif
season
influenza
virus
circul
human
popul
also
unusu
subtyp
avian
origin
gene
encod
intern
viru
protein
nonstructur
ns
protein
highli
conserv
among
differ
influenza
virus
thu
use
target
univers
detect
viru
type
sinc
influenza
viru
subtyp
defin
basi
differ
surfac
glycoprotein
haemagglutinin
neuraminidas
gene
target
effect
recommend
approach
specif
subtyp
influenza
virus
present
studi
correspond
gene
also
shown
use
differenti
specif
type
subtyp
howev
larg
variabl
among
strain
two
primerprob
set
select
effici
detect
probe
label
fluorophor
duplex
reaction
design
identif
without
differenti
multiplex
qpcr
amplicon
discrimin
use
distinct
fluorogen
probe
nucleic
acid
target
altern
melt
curv
nonspecif
dnaintercal
fluorophor
use
detect
method
limit
number
fluorophor
show
signific
overlap
emiss
spectra
well
finit
number
emiss
channel
qpcr
instrument
limit
number
target
detect
singl
reaction
multiplex
present
studi
lightcycl
system
led
light
sourc
use
duplex
format
reaction
base
hydrolysi
probe
label
joe
report
dye
quencher
california
fluor
red
quencher
despit
two
differ
emiss
maxima
fluorophor
measur
fluoresc
two
differ
detect
channel
nm
joe
nm
california
fluor
red
use
color
compens
softwar
necessari
due
overlap
fluoresc
accord
literatur
data
well
result
data
shown
lightcycl
appropri
wellwork
platform
detect
two
differ
fluorophor
singl
reaction
taqman
probe
design
primer
probe
set
label
propos
format
differ
combin
valid
use
duplex
format
complet
identif
specif
subtyp
includ
haemagglutinin
neuraminidas
gene
possibl
clinic
evalu
base
respiratori
specimen
collect
patient
influenza
symptom
three
epidem
season
concord
rate
result
newli
develop
valid
duplex
qpcr
monoplex
qpcr
assay
recommend
cdc
nevertheless
comparison
assay
show
advantag
molecular
method
discrep
result
qpcr
ifa
compris
total
newli
develop
assay
result
eight
addit
posit
miss
routin
method
moreov
three
specimen
posit
influenza
viru
ifa
actual
neg
qpcr
assay
also
viru
isol
data
shown
gave
neg
result
data
consist
numer
report
show
pcrbase
method
sensit
ifa
detect
viral
infect
differ
detect
virus
variou
test
explain
least
partial
differ
target
use
method
sensit
ifa
significantli
influenc
qualiti
specimen
sinc
virusinfect
cell
labil
may
easi
damag
inappropri
handl
storag
clinic
specimen
process
moreov
analysi
interpret
result
obtain
ifa
often
subject
depend
experi
investig
molecular
method
allow
detect
nucleic
acid
viabl
well
nonviabl
virus
even
viral
copi
number
low
thu
exhibit
highest
sensit
although
pcr
method
may
affect
pcr
inhibitor
occurr
inhibit
amplif
respiratori
specimen
rare
among
respiratori
specimen
test
stauffer
et
al
inhibit
pcr
addit
rnadnadegrad
enzym
present
specimen
well
reagent
degrad
may
reduc
sensit
pcr
detect
season
avian
influenza
virus
use
qpcr
reaction
therefor
apart
neg
posit
control
intern
control
confirm
presenc
human
nucleic
acid
indic
accept
qualiti
specimen
templat
also
use
run
duplex
assay
describ
intern
control
includ
thu
neg
sampl
test
presenc
inhibitor
elimin
fals
neg
result
anoth
limit
principl
pcr
fact
influenza
virus
especi
influenza
viru
evolv
constantli
one
hand
high
specif
primer
probe
crucial
qpcr
assay
hand
nucleotid
variat
primerprob
bind
region
newli
emerg
strain
may
lead
much
lower
effici
hybridis
primer
probe
templat
consequ
signific
decreas
assay
sensit
even
fals
result
obtain
thu
use
differ
target
gene
assay
appropri
correct
detect
identif
circul
influenza
virus
detect
one
gene
inclus
highli
conserv
region
two
differ
target
gene
ha
na
assay
describ
definit
increas
possibl
detect
new
influenza
strain
significantli
decreas
risk
event
mutat
detect
specif
viru
fail
present
studi
select
target
sequenc
use
qpcr
assay
contribut
fals
neg
result
conclus
three
newli
develop
valid
duplex
qpcr
assay
capabl
rapid
accur
simultan
detect
influenza
virus
allow
influenza
b
viru
current
circul
strain
human
season
influenza
virus
well
avian
influenza
differenti
assay
run
thermal
condit
provid
valuabl
method
influenza
surveil
earli
diagnosi
